PHASE-II RANDOMIZED TRIAL COMPARING HIGH-DOSE CISPLATIN WITH MODERATE-DOSE CISPLATIN AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER

被引：56

作者：

SCULIER, JP

KLASTERSKY, J

GINER, V

BUREAU, G

THIRIAUX, J

DABOUIS, G

EFREMIDIS, A

RIES, F

BERCHIER, MC

SERGYSELS, R

MOMMEN, P

PAESMANS, M

机构：

[1] HOSP DOCTOR PESET,VALENCIA,SPAIN

[2] GRP MED ST REMI,REIMS,FRANCE

[3] CHU NANTES,NANTES,FRANCE

[4] HOSP ST SAVAS,ATHENS,GREECE

[5] CTR HOSP LUXEMBOURG,LUXEMBOURG,LUXEMBOURG

[6] HOP HAYANGE,HAYANGE,FRANCE

[7] HOP ST PIERRE & ERASME,BRUSSELS,BELGIUM

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 02期

关键词：

D O I：

10.1200/JCO.1994.12.2.353

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：353 / 359

页数：7

共 36 条

[1] MODIFICATION OF CISPLATIN TOXICITY WITH DIETHYLDITHIOCARBAMATE [J].

BERRY, JM ;

JACOBS, C ;

SIKIC, B ;

HALSEY, J ;

BORCH, RF .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1585-1590

[2] COMBINATION CHEMOTHERAPY VERSUS SINGLE AGENTS FOLLOWED BY COMBINATION CHEMOTHERAPY IN STAGE-IV NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].

BONOMI, PD ;

FINKELSTEIN, DM ;

RUCKDESCHEL, JC ;

BLUM, RH ;

GREEN, MD ;

MASON, B ;

HAHN, R ;

TORMEY, DC ;

HARRIS, J ;

COMIS, R ;

GLICK, J .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1602-1613

[3] COMBINING CISPLATIN AND CARBOPLATIN COMPLEMENTARY OR CONTRADICTORY [J].

CALVERT, AH .

ANNALS OF ONCOLOGY, 1991, 2 (02) :89-91

[4] CISPLATIN NEPHROTOXICITY - A REVIEW [J].

DAUGAARD, G ;

ABILDGAARD, U .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (01) :1-9

[5]

DEJAGER R, 1980, CANCER TREAT REP, V64, P1341

[6]

DONNADIEU N, 1991, LUNG CANCER, V7, P243

[7] RANDOM PROSPECTIVE-STUDY OF VINDESINE VERSUS VINDESINE PLUS HIGH-DOSE CISPLATIN VERSUS VINDESINE PLUS CISPLATIN PLUS MITOMYCIN-C IN ADVANCED NON-SMALL-CELL LUNG-CANCER [J].

EINHORN, LH ;

LOEHRER, PJ ;

WILLIAMS, SD ;

MEYERS, S ;

GABRYS, T ;

NATTAN, SR ;

WOODBURN, R ;

DRASGA, R ;

SONGER, J ;

FISHER, W ;

STEPHENS, D ;

HUI, S .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) :1037-1043

[8] VINDESINE AND CISPLATIN COMBINATION CHEMOTHERAPY COMPARED WITH VINDESINE AS A SINGLE AGENT IN THE MANAGEMENT OF NON-SMALL CELL LUNG-CANCER - A RANDOMIZED STUDY [J].

ELLIOTT, JA ;

AHMEDZAI, S ;

HOLE, D ;

DORWARD, AJ ;

STEVENSON, RD ;

KAYE, SB ;

BANHAM, SW ;

STACK, BHR ;

CALMAN, KC .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08) :1025-1032

[9] RANDOMIZED STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATINUM IN NON-SMALL CELL LUNG-CANCER [J].

FUKS, JZ ;

AISNER, J ;

VANECHO, DA ;

SCHIPPER, H ;

LEVITT, M ;

OSTROW, S ;

WIERNIK, PH .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (05) :295-301

[10] HIGH-DOSE CISPLATIN IN HYPERTONIC SALINE - REDUCED TOXICITY OF A MODIFIED DOSE SCHEDULE AND CORRELATION WITH PLASMA PHARMACOKINETICS - A NORTHERN CALIFORNIA ONCOLOGY GROUP PILOT-STUDY IN NON-SMALL-CELL LUNG-CANCER [J].

GANDARA, DR ;

DEGREGORIO, MW ;

WOLD, H ;

WILBUR, BJ ;

KOHLER, M ;

LAWRENCE, HJ ;

DEISSEROTH, AB ;

GEORGE, CB .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) :1787-1793

← 1 2 3 4 →